Aerosol therapy with colistin methanesulfonate: A biopharmaceutical issue illustrated in rats

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3702-3707

  Marchand, Sandrine ^a,b,c   Gobin, Patrice ^a,c   Brillault, Julien ^a,b   Baptista, Sara ^a,b   Adier, Christophe ^a,c   Olivier, Jean Christophe ^a,b   Mimoz, Olivier ^a,b,c   Couet, William ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MALE; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; CHROMATOGRAPHY, LIQUID; COLISTIN; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY;

EID: 77956097758     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00411-10     Document Type: Article

References (31)

1. Bergen, P. J., J. Li, C. R. Rayner, and R. L. Nation. 2006. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:1953-1958.
2. Berlana, D., J. M. Llop, E. Fort, M. B. Badia, and R. Jodar. 2005. Use of colistin in the treatment of multiple-drug-resistant Gram-negative infections. Am. J. Health Syst. Pharm. 62:39-47.
3. Brillault, J., W. V. De Castro, and W. Couet. 2010. Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model. Antimicrob. Agents Chemother. 54:543-545.
4. Brillault, J., W. V. De Castro, T. Harnois, A. Kitzis, J. C. Olivier, and W. Couet. 2009. P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model. Antimicrob. Agents Chemother. 53:1457-1462.
5. Chandenier, J., S. Bernard, J. Montharu, E. Bailly, F. Fetissof, M. de Monte, G. Desoubeaux, P. Diot, and D. Richard-Lenoble. 2009. The utility of a nebulised intra-tracheal rat model of invasive pulmonary aspergillosis. Mycoses 52:239-245.
6. Conte, J. E., Jr., J. A. Golden, M. G. Kelley, and E. Zurlinden. 2005. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem. Int. J. Antimicrob. Agents 26:449-456.
7. Conte, J. E., Jr., J. A. Golden, M. McIver, E. Little, and E. Zurlinden. 2007. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease. Int. J. Antimicrob. Agents 30:422-427.
8. Conte, J. E., Jr., J. A. Golden, M. McIver, and E. Zurlinden. 2006. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects. Int. J. Antimicrob. Agents 28:114-121.
9. Dudley, M. N., J. Loutit, and D. C. Griffith. 2008. Aerosol antibiotics: considerations in pharmacological and clinical evaluation. Curr. Opin. Biotechnol. 19:637-643.
10. Falagas, M. E., and S. K. Kasiakou. 2006. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit. Care 10:R27.
11. Falagas, M. E., S. K. Kasiakou, S. Tsiodras, and A. Michalopoulos. 2006. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin. Med. Res. 4:138-146.
12. Falagas, M. E., I. I. Siempos, P. I. Rafailidis, I. P. Korbila, E. Ioannidou, and A. Michalopoulos. 2009. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Respir. Med. 103: 707-713.
13. Geller, D. E. 2009. Aerosol antibiotics in cystic fibrosis. Respir. Care 54:658-670.
14. Gobin, P., F. Lemaitre, S. Marchand, W. Couet, and J. C. Olivier. 2010. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography tandem mass spectrometry (LC-MS/MS). Antimicrob. Agents Chemother. 54:1941-1948.
15. Grégoire, N., P. Gobin, C. Grignon, D. Frasca, P. Saulnier, W. Couet, and O. Mimoz. 2008. Pharmacokinetic modelling of colistin methansilfonate (CMS) and colistin in healthy volunteers after intravenous infusion od CMS, abstr. A1668. Abstr. 48th Annu. Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC)-Infect. Dis. Soc. Am. (IDSA) 46th Annu. Meet. American Society for Microbiology and Infectious Diseases Society of America, Washington, DC.
16. Hoiby, N., B. Frederiksen, and T. Pressler. 2005. Eradication of early Pseudomonas aeruginosa infection. J. Cyst. Fibros. 4(Suppl. 2):49-54.
17. Kiem, S., and J. J. Schentag. 2008. Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob. Agents Chemother. 52:24-36.
18. Korbila, I. P., A. Michalopoulos, P. I. Rafailidis, D. Nikita, G. Samonis, and M. E. Falagas. 2009. Inhaled colistin as adjunctive to intravenous colistin for the treatment of microbiologically documented VAP: a comparative cohort study. Clin. Microbiol. Infect. [Epub ahead of print.]
19. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, and K. Coulthard. 2003. Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography. Antimicrob. Agents Chemother. 47:1364-1370.
20. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, T. C. Smeaton, and K. Coulthard. 2004. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. J. Antimicrob. Chemother. 53:837-840.
21. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, T. C. Smeaton, and K. Coulthard. 2003. Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrob. Agents Chemother. 47:1766-1770.
22. Li, J., and R. L. Nation. 2006. Comment on: pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J. Antimicrob. Chemother. 58:222-223.
23. Li, J., R. L. Nation, J. D. Turnidge, R. W. Milne, K. Coulthard, C. R. Rayner, and D. L. Paterson. 2006. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
24. Marchetti, F., L. Giglio, M. Candusso, D. Faraguna, and B. M. Assael. 2004. Early antibiotic treatment of Pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature. Eur. J. Clin. Pharmacol. 60:67-74.
25. Michalopoulos, A., D. Fotakis, S. Virtzili, C. Vletsas, S. Raftopoulou, Z. Mastora, and M. E. Falagas. 2008. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir. Med. 102:407-412.
26. Michalopoulos, A., S. K. Kasiakou, Z. Mastora, K. Rellos, A. M. Kapaskelis, and M. E. Falagas. 2005. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit. Care 9:R53-R59.
27. National Institutes of Health. 1985. Principles of laboratory animal care. Publication 85-23. National Institutes of Health, Bethesda, MD.
28. Pierson, R. N., Jr., D. C. Price, J. Wang, and R. K. Jain. 1978. Extracellular water measurements: organ tracer kinetics of bromide and sucrose in rats and man. Am. J. Physiol. 235:F254-F264.
29. Plachouras, D., M. Karvanen, L. E. Friberg, E. Papadomichelakis, A. Antoniadou, I. Tsangaris, I. Karaiskos, G. Poulakou, F. Kontopidou, A. Armaganidis, O. Cars, and H. Giamarellou. 2009. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria. Antimicrob. Agents Chemother. 53:3430-3436.
30. Ratjen, F., E. Rietschel, D. Kasel, R. Schwiertz, K. Starke, H. Beier, S. van Koningsbruggen, and H. Grasemann. 2006. Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J. Antimicrob. Chemother. 57:306-311.
31. Westerman, E. M., P. P. Le Brun, D. J. Touw, H. W. Frijlink, and H. G. Heijerman. 2004. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study. J. Cyst. Fibros. 3:23-28.